Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001209191-14-067902

Chief Scientific Officer acquired 239,952 shares (option exercise)

  • Chief Scientific Officer acquired 46,718 shares (conversion)
  • Chief Scientific Officer disposed of 26,756 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Herman Alan C. · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-12 Option exercise : show line 1 in the form +239,952 $1.67 $400,000 239,952 D
2014-11-12 Other disposition : show line 2 in the form −26,756 213,196 D
2014-11-12 Conversion : show line 3 in the form +1,503 214,699 D
2014-11-12 Conversion : show line 4 in the form +39,991 294,940 I
2014-11-12 Conversion : show line 5 in the form +5,224 300,164 I

Table II: Derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-12 Option exercise : show line 6 in the form Warrant to Purchase Common Stock −239,952 0 D
2014-11-12 Option exercise : show line 7 in the form Warrant to Purchase Series B Preferred Stock −1,505 0 D
2014-11-12 Option exercise : show line 8 in the form Series B Preferred Stock +1,505 $0.02 $25 1,505 D
2014-11-12 Other disposition : show line 9 in the form Series B Preferred Stock −2 1,503 D
2014-11-12 Conversion : show line 10 in the form Series B Preferred Stock −1,503 0 D
2014-11-12 Conversion : show line 11 in the form Series A Preferred Stock −39,991 0 I
2014-11-12 Conversion : show line 12 in the form Series B Preferred Stock −5,224 0 I
Loading xslF345X03/doc4.xml…